The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Reprod Biol Endocrinol. 2023 Jun 9;21(1):53. doi: 10.1186/s12958-023-01101-w.
Sertoli cell-only syndrome (SCOS) is the most serious pathological type of non-obstructive azoospermia. Recently, several genes related to SCOS have been identified, including FANCM, TEX14, NR5A1, NANOS2, PLK4, WNK3, and FANCA, but they cannot fully explain the pathogenesis of SCOS. This study attempted to explain spermatogenesis dysfunction in SCOS through testicular tissue RNA sequencing and to provide new targets for SCOS diagnosis and therapy.
We analyzed differentially expressed genes (DEGs) based on RNA sequencing of nine patients with SCOS and three patients with obstructive azoospermia and normal spermatogenesis. We further explored the identified genes using ELISA and immunohistochemistry.
In total, 9406 DEGs were expressed (Log2|FC|≥ 1; adjusted P value < 0.05) in SCOS samples, and 21 hub genes were identified. Three upregulated core genes were found, including CASP4, CASP1, and PLA2G4A. Thus, we hypothesized that testis cell pyroptosis mediated by CASP1 and CASP4 might be involved in SCOS occurrence and development. ELISA verified that CASP1 and CASP4 activities in the testes of patients with SCOS were significantly higher than those in patients with normal spermatogenesis. Immunohistochemical results showed that CASP1 and CASP4 in the normal spermatogenesis group were mainly expressed in the nuclei of spermatogenic, Sertoli, and interstitial cells. CASP1 and CASP4 in the SCOS group were mainly expressed in the nuclei of Sertoli and interstitial cells because of the loss of spermatogonia and spermatocytes. CASP1 and CASP4 expression levels in the testes of patients with SCOS were significantly higher than those in patients with normal spermatogenisis. Furthermore, the pyroptosis-related proteins GSDMD and GSDME in the testes of patients with SCOS were also significantly higher than those in control patients. ELISA also showed that inflammatory factors (IL-1 β, IL-18, LDH, and ROS) were significantly increased in the SCOS group.
For the first time, we found that cell pyroptosis-related genes and key markers were significantly increased in the testes of patients with SCOS. We also observed many inflammatory and oxidative stress reactions in SCOS. Thus, we propose that testis cell pyroptosis mediated by CASP1 and CASP4 could participate in SCOS occurrence and development.
唯支持细胞综合征(Sertoli cell-only syndrome,SCOS)是最严重的非梗阻性无精子症的病理类型。最近,已经发现了几个与 SCOS 相关的基因,包括 FANCM、TEX14、NR5A1、NANOS2、PLK4、WNK3 和 FANCA,但它们不能完全解释 SCOS 的发病机制。本研究试图通过睾丸组织 RNA 测序来解释 SCOS 中的生精功能障碍,并为 SCOS 的诊断和治疗提供新的靶点。
我们基于 9 例 SCOS 患者和 3 例梗阻性无精子症但生精正常患者的 RNA 测序,分析差异表达基因(differentially expressed genes,DEGs)。我们进一步使用 ELISA 和免疫组织化学方法对鉴定出的基因进行了探索。
SCOS 样本中共有 9406 个 DEGs(Log2|FC|≥1;调整后的 P 值<0.05),鉴定出 21 个枢纽基因。发现了 3 个上调的核心基因,包括 CASP4、CASP1 和 PLA2G4A。因此,我们假设 CASP1 和 CASP4 介导的睾丸细胞焦亡可能参与了 SCOS 的发生和发展。ELISA 验证了 SCOS 患者睾丸中 CASP1 和 CASP4 的活性明显高于生精正常患者。免疫组织化学结果显示,正常生精组的 CASP1 和 CASP4 主要在精原细胞、支持细胞和间质细胞的核内表达。SCOS 组的 CASP1 和 CASP4 主要在支持细胞和间质细胞的核内表达,因为精原细胞和精母细胞丢失。SCOS 患者睾丸中 CASP1 和 CASP4 的表达水平明显高于生精正常患者。此外,SCOS 患者睾丸中的焦亡相关蛋白 GSDMD 和 GSDME 也明显高于对照组。ELISA 还显示,SCOS 组的炎症因子(IL-1β、IL-18、LDH 和 ROS)明显增加。
我们首次发现 SCOS 患者睾丸中细胞焦亡相关基因和关键标志物明显增加,并且观察到 SCOS 中存在许多炎症和氧化应激反应。因此,我们提出 CASP1 和 CASP4 介导的睾丸细胞焦亡可能参与 SCOS 的发生和发展。